MedRx Co., Ltd
Notice of Completion of Exercise of the 35th Share Acquisition Rights Issued by Third-Party Allotment (with Exercise Price Adjustment Clause) and Monthly Exercise Status
All exercises of the 35th share acquisition rights have been completed. In the subject month, 28,396 rights were exercised (19.21% of the total issued 147,820), and deliveries during the month totaled 2,839,600 shares including multiple exercise dates since the start of the month. The remaining unexercised rights are now zero. The total number of issued shares is 74,147,100 shares and the capital is 418 million yen.
Key Figures
- Total number of issued shares: 74,147,100 shares
- Capital: 418 million yen
- Number of these share acquisition rights issued: 147,820 cases
AI要約
Completion of Exercise of Share Acquisition Rights and Monthly Exercise Status
Today, payment for all exercises of the 35th share acquisition rights issued by third-party allotment was completed. During the subject month, 2,839,600 shares were delivered, and the number of share acquisition rights exercised in the month was 28,396 cases (19.21% of the total issued). All unexercised rights have been fully exercised, resulting in zero remaining rights. The current total number of issued shares is 74,147,100 shares and capital is 418 million yen.
Proceeds and Future Share Structure
The funds procured from the exercise of the share acquisition rights amount to 718 million yen (approximate net proceeds), and the allottee is Growth Capital Co., Ltd. The issuance date was June 5, 2026, and with the completion of these exercises, the exercise restriction ratio stands at 4.78% (combined for three or more points). The shareholder composition and dilution impact are finalized with the completion of these exercises, and there are no additional share acquisition rights remaining.
MedRx Co., Ltd
Company overview · Stock price · Financial data · All IR